Monday, February 24, 2020 NIAID Now: Interferon "Fingerprint" Refines Diagnoses of Rare Autoinflammatory Diseases, Identifies Three New Conditions Image: Orange autoinflammatory diseases awareness ribbon Medicine has recognized rare autoinflammatory diseases for just over 20 years. While early diagnosis and treatment can improve patient outcomes, similar symptoms across different autoinflammatory diseases can make them difficult to diagnose and manage. Now, NIAID scientists and their colleagues have developed an integrated approach that combines next-generation genetic sequencing with advanced diagnostic techniques to characterize inflammatory responses. In doing so, investigators discovered three new autoinflammatory diseases. Their findings were published today in The Journal of Clinical Investigation. National Institute of Allergy and Infectious Diseases  |  National Institutes of Health Update your subscriptions, modify your password or e-mail address, or stop subscriptions at any time on your Subscriber Preferences Page. You will need to use your e-mail address to log in. If you have questions or problems with the subscription service, please contact Subscriber Help. This service is provided to you at no charge by National Institute of Allergy and Infectious Diseases (NIAID). This email was sent to myhcistech.healthnews360@blogger.com using GovDelivery Communications Cloud on behalf of: National Institute of Allergy and Infectious Diseases · 5601 Fishers Lane · Bethesda, MD 20892 · 1-866-284-4107